Abstract
Background & Objectives: The aim of this study is to know if the liver function tests (LFT), particularly gamma glutamyl transferase (GGT), have a analytical value in diagnosis of metabolic syndrome (MS).
Methods: A cross-sectional, single-center study was carried out with 500 subjects. While other 250 were sex and age matched healthy control subjects. Blood pressure, liver function tests, fasting blood glucose levels and lipid profile of the subjects were recorded.
Results: The denote values of alanine amino transferase (ALT), aspartate aminotransferase (AST) and GGT levels were statistically significantly superior in MS group. The denote values of liver enzymes, for female/ male subjects in MS group, AST; ALT and GGT respectively. When the sample is divided into quartiles of the GGT levels, increase in GGT is positively correlated with increased MS prevalence. In ROC analysis GGT is as strongly associated with the IDF diagnostic components as is each individual IDF component, except elevated systolic blood pressure. In covariance analysis, there was significant relationship between elevated GGT levels and MS presence after adjustment for age, sex and MS diagnostic criteria; but not AST and ALT levels. In multivariance analysis, in MS group, a high GGT was positively associated with CVD prevalance compared to low GGT group independent of age, sex and smoking habits.
Interpretation & Conclusion: Eminent liver enzymes, though in normal ranges, particularly at higher quartiles, play a middle part in early diagnosis of fat overflow to the liver. Concerning the accessibility and ease of these tests in routine clinical practice, they, particularly GGT, have potential to be considered in algorithms for metabolic syndrome.
Keywords: Gamma Glutamyl Transferase (GGT), Alanine Amino Transferase (ALT), Aspartate Aminotransferase (AST).
References
- Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109 : 433-8.
- Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26 : 3153-9.
- Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group : The metabolic syndrome: a new worldwide definition. Lancet 2005; 366 : 1059-62.
- Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol
- Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98 : 960-7.
- Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87 : 3023-8.
- Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19 : 854-8.
- Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21 : 17-26.
- Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004; 8 : 501-19, vii.
- Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, Vorarlberg Health Monitoring and Promotion Program Study Group. Gammaglutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112 : 2130-7.
- Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49 : 1358-66.
- Jousilahti P, Rastenyte D, Tuomilehto J. Serum g-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31 : 1851-5.
- Balogun W18. O, Adeleye JO, Akinlade KS, Adedapo KS, Kuti M. Frequent occurrence of high gamma-glutamyl transferase and alanine amino transferase among Nigerian patients with type 2 diabetes. Afr J Med Med Sci 2008; 37 : 177-83.
Corresponding Author
Dr Laxminarayan Meena
Sr. Demonstrator, Department of Biochemistry, National Institute of Medical Sciences & Research, Jaipur, Rajasthan, India
DOI: https://dx.doi.org/10.18535/jmscr/v9i7.01
